These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36119530)
1. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. Liu C; Qin H; Liu H; Wei T; Wu Z; Shang M; Liu H; Wang A; Liu J; Shang D; Yin P Front Oncol; 2022; 12():991051. PubMed ID: 36119530 [TBL] [Abstract][Full Text] [Related]
2. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis. Luo X; Liu J; Wang H; Lu H Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036 [TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer. Xiong Y; Shi C; Zhong F; Liu X; Yang P Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985 [TBL] [Abstract][Full Text] [Related]
4. Development of a lipid metabolism-related gene model to predict prognosis in patients with pancreatic cancer. Xu H; Sun J; Zhou L; Du QC; Zhu HY; Chen Y; Wang XY World J Clin Cases; 2021 Dec; 9(35):10884-10898. PubMed ID: 35047599 [TBL] [Abstract][Full Text] [Related]
5. Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer. Li Z; Ma Z; Zhou Q; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Wu Z; Zhao J; Huang S; Zhang C; Hou B Heliyon; 2022 Nov; 8(11):e11321. PubMed ID: 36406681 [TBL] [Abstract][Full Text] [Related]
6. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry]. Gu Y; Zang P; Li J; Yan Y; Wang J Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841 [TBL] [Abstract][Full Text] [Related]
7. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
9. Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis. Qiu X; Hou QH; Shi QY; Jiang HX; Qin SY Front Genet; 2020; 11():595361. PubMed ID: 33363572 [TBL] [Abstract][Full Text] [Related]
10. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes. He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859 [TBL] [Abstract][Full Text] [Related]
11. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry. Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245 [TBL] [Abstract][Full Text] [Related]
12. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790 [TBL] [Abstract][Full Text] [Related]
13. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415 [TBL] [Abstract][Full Text] [Related]
14. Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer. Jiang W; Qiao L; Zuo D; Qin D; Xiao J; An H; Wang Y; Zhang X; Jin Y; Ren L Ann Transl Med; 2021 Feb; 9(4):358. PubMed ID: 33708985 [TBL] [Abstract][Full Text] [Related]
15. A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer. Zhou X; Huang Z; Xu L; Zhu M; Zhang L; Zhang H; Wang X; Li H; Zhu W; Shu Y; Liu P Oncotarget; 2016 Oct; 7(43):69616-69624. PubMed ID: 27626307 [TBL] [Abstract][Full Text] [Related]
17. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA. Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263 [TBL] [Abstract][Full Text] [Related]
18. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry. Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249 [TBL] [Abstract][Full Text] [Related]